September is Blood Cancer Awareness Month, and this month, not only do we want to recognize patients impacted by these diseases, but the entire cancer care community including the researchers, scientists, physicians, nurses and caregivers who make a difference in patients' lives every day.
Did you know that an estimated 171,550 people in the U.S. are expected to be diagnosed with a blood cancer in 2016?1 These types of cancer typically begin in the bone marrow, and prevent the blood from performing normal functions, including fighting infections or preventing serious bleeding.2
More than 1.2 million people in the U.S. are either living with or are in remission from leukemia, lymphoma or myeloma.1
While a blood cancer diagnosis can be scary for patients, critical advances have been made across diseases over the past several years.1
Amgen is proud to be at the forefront of this research and is committed to continuing to find solutions for patients with the toughest blood cancers, but we can't do it alone. During Blood Cancer Awareness month we would like to extend a heartfelt thank you to the patients that have participated in clinical trials, which helped lead to the advances we're seeing today and to the researchers, physicians and nurses who have worked tirelessly to find new pathways and approaches to treating these diseases.
This year, Amgen is proud to return as National Sponsor of the Leukemia & Lymphoma Society's Light the Night Walk. Light The Night is an inspirational evening walking event that raises awareness and funding for groundbreaking research and treatment options. Find out more here.
Together, we are changing lives every day of the year!
REFERENCES
- Leukemia & Lymphoma Society. Facts and Statistics. 2016. Available at: http://www.lls.org/facts-and-statistics/facts-and-statistics-overview. Accessed: August 19, 2016.
- American Society of Hematology. Blood Cancers. 2016. Available at: http://www.hematology.org/Patients/Cancers/. Accessed: August 19, 2016.